The DEA (US drug enforcement agency) almost certainly will not change the legal status of magic mushrooms or MDMA in the next six months. That's because no approved medicine using these drugs exists yet, and rescheduling requires years of bureaucratic work.
DEA rescheduling requires either an HHS recommendation or a petitioner-initiated process that historically takes years. FDA declined to approve MDMA-assisted therapy in 2024; psilocybin has no pending NDA. Without an approved NDA or extraordinary political intervention, DEA has no administrative trigger to reschedule. The six-month window is far too short for a rescheduling petition to complete notice-and-comment rulemaking. Resolves YES if both substances remain Schedule I on October 30, 2026.